Evidence map›Paper›PMID 29071491›Full record

ArticleBreast cancer research and treatment2018

Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.

Carlo Palmieri, Rob C Stein, Xinxue Liu, Emma Hudson, Hanna Nicholas, Hironobu Sasano, Fouzia Guestini, Chris Holcombe, Sophie Barrett, Laura Kenny and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer research and treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Carlo PalmieriDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK. c.palmieri@liverpool.ac.uk.ORCID 0000-0001-9496-2718
Rob C SteinNIHR University College London Hospitals Biomedical Research Centre, London, NW1 2PG, UK.
Xinxue LiuDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Emma HudsonDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Hanna NicholasDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Hironobu SasanoDepartment of Pathology, Tohoku University School of Medicine, Sendai, Japan.
Fouzia GuestiniDepartment of Pathology, Tohoku University School of Medicine, Sendai, Japan.
Chris HolcombeBreast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, L7 8XP, UK.
Sophie BarrettBeatson West of Scotland Cancer Centre, Glasgow, G12 0YN, UK.
Laura KennyDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Sadie ReedDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Adrian LimDepartment of Radiology, Imperial College NHS Foundation Trust, London, W8 6RF, UK.
Larry HaywardEdinburgh Cancer Centre, Western General Hospital, Edinburgh, EH4 2XU, UK.
Sacha HowellDepartment of Medical Oncology, The University of Manchester, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
R Charles CoombesDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
IRIStrial participants

Funding

Cancer Research UK 13392
6 · The paper itself

Abstract

In the original publication of the article, a part of acknowledgement section was missed out. The omitted acknowledgement is given below: 'The study was coordinated by the Imperial Clinical Trials Unit-Cancer, Imperial College London and Sponsored by Imperial College London. The Imperial Clinical Trials Unit receives funding from the National Institute for Health (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This study was supported by Imperial Experimental Cancer Medicine Centre and Cancer Research UK Imperial Centre'.

Identifiers

PMID29071491
PMCPMC6828374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.